Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. حسب Spela Kokelj (8356644)

الموضوعات:

Symptoms reported by COVID-19 cases at baseline and at follow-up. حسب Spela Kokelj (8356644)

الموضوعات:

Effects of BM-MSCs on ROS generation in DCS rats. حسب Chen Lu (135200)

الموضوعات:

Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. حسب Chen Lu (135200)

الموضوعات:

Isotype control overlays. حسب Chen Lu (135200)

الموضوعات:

Original uncropped blot. حسب Chen Lu (135200)

الموضوعات:

Characterization of BM-MSC. حسب Chen Lu (135200)

الموضوعات:

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. حسب Chen Lu (135200)

الموضوعات:

Utilization of anticoagulants at eight hospitals from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

The ANCOVA and Post_hoc results. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

The demographical and clinical characteristics of subjects at baseline. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Identification of BM-MSCs. حسب Chen Lu (135200)

الموضوعات:

CONSORT flowchart. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Indications for warfarin prescription in outpatients and inpatients in 2023. حسب Wei Luo (80175)

الموضوعات:

Time to stabilization in the mediolateral direction. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Outpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Participant’s data including characteristics and primary outcome measurement. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Effects of BM-MSCs on different types of lung cell death in different group. حسب Chen Lu (135200)

الموضوعات:

Time to stabilization in the vertical direction. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات: